Summit Therapeutics

(NASDAQ) SMMT

Current Price$16.84

Market Cap$12.29B

Since IPO (2015)+54%

5 Year+110%

1 Year-34%

1 Month-37%

Summit Therapeutics Financials at a Glance

Market Cap

$12.29B

Revenue (TTM)

$0.00

Net Income (TTM)

$1.05B

EPS (TTM)

$-1.60

P/E Ratio

-9.88

Dividend

$0.00

Beta (Volatility)

1.00 (Average)

Dividend

$0.00

Beta (Volatility)

1.00 (Average)

Price

$16.84

Volume

57,433.589

Open

$16.13

Price

$16.84

Volume

57,433.589

Open

$16.13

Previous Close

$15.85

Daily Range

$16.13 - $16.53

52-Week Range

$13.83 - $30.98

Dividend

$0.00

Beta (Volatility)

1.00 (Average)

Price

$16.84

Volume

57,433.589

Open

$16.13

Previous Close

$15.85

Daily Range

$16.13 - $16.53

52-Week Range

$13.83 - $30.98

SMMT News

Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now

Prosper Junior BakinyMar 25, 2026

2 Stocks Up Over 600% in the Past 3 Years With More Room to Run

Prosper Junior BakinyDec 9, 2025

Doctor talking to a patient while making notes.

Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now?

David Jagielski, CPADec 5, 2025

Page 1

SMMT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Summit Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

265

CEO

Robert William Duggan; Mahkam Zanganeh, DDS, MBA

Website

www.smmttx.com

Headquarters

Cambridge, MA 02142, US

SMMT Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-271%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-10.12%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.29B

Shares Outstanding

775.37M

Volume

57.43K

Avg. Volume

3.41M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$1.09B

EBITDA

$1.08B

Operating Cash Flow

$239.67M

Capital Expenditure

$487.60K

Free Cash Flow

$240.15M

Cash & ST Invst.

$529.49M

Total Debt

$15.50M

Summit Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$12.29B

N/A

Market Cap/Employee

$77.29M

N/A

Employees

159

N/A

Net Income

$189.42M

-289.0%

EBITDA

$195.17M

-277.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$438.86M

+59.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$12.79M

+467.8%

Short Term Debt

$2.41M

-12.1%

Return on Assets

-2.14%

N/A

Return on Invested Capital

-2.50%

N/A

Free Cash Flow

$92.93M

-94.8%

Operating Cash Flow

$92.74M

-95.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IONSIonis Pharmaceuticals, Inc.

IONSIonis Pharmaceuticals, Inc.$74.92+1.47%

BBIOBridgeBio Pharma, Inc.

BBIOBridgeBio Pharma, Inc.$67.82+2.76%

UHSUniversal Health Services, Inc.

UHSUniversal Health Services, Inc.$165.61-0.50%

ASNDAscendis Pharma A/S

ASNDAscendis Pharma A/S$239.79+0.76%

MRNAModerna, Inc.

MRNAModerna, Inc.$47.15+3.12%

EXASExact Sciences Corporation

EXASExact Sciences Corporation$104.91+0.00%

ROIVRoivant Sciences Ltd.

ROIVRoivant Sciences Ltd.$31.36+11.17%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CCLCarnival Corp.

CCLCarnival Corp.$23.89-0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.79-0.03%

INFYInfosys

INFYInfosys$12.72+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$44.37+0.02%

IBRXImmunityBio

IBRXImmunityBio$7.76-0.03%

INTCIntel

INTCIntel$117.71+0.06%

TET1 Energy Inc.

TET1 Energy Inc.$6.88-0.02%

Questions About SMMT

What is the current price of Summit Therapeutics?

Summit Therapeutics is trading at $16.53 per share.

What is the 52-week range for Summit Therapeutics?

Over the past 52 weeks, Summit Therapeutics has traded between $13.83 and $30.98.

How much debt does Summit Therapeutics have?

As of the most recent reporting period, Summit Therapeutics reported total debt of $20.04M.

How much cash does Summit Therapeutics have on hand?

Summit Therapeutics reported $106.83M in cash and cash equivalents in its most recent financial results.

What is Summit Therapeutics’s dividend yield?

Summit Therapeutics does not currently have a dividend yield.

Summit Therapeutics

Summit Therapeutics Financials at a Glance

SMMT News

Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now

2 Stocks Up Over 600% in the Past 3 Years With More Room to Run

Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now?

Don't Buy Summit Therapeutics Until This Big Thing Happen

1 Monster Stock in the Making to Buy and Hold

Summit Therapeutics: A Risky Bet in the Biotech Arena?

1 Monster Stock in the Making to Buy and Hold

Is Summit Therapeutics a Buy, Sell, or Hold Now?

SMMT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Summit Therapeutics

SMMT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Summit Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SMMT

What is the current price of Summit Therapeutics?

What is the 52-week range for Summit Therapeutics?

How much debt does Summit Therapeutics have?

How much cash does Summit Therapeutics have on hand?

What is Summit Therapeutics’s dividend yield?

Premium Investing Services